Prothena Corp Public (PRTA) Current Deferred Tax Assets (2012 - 2015)

Prothena Corp Public's (PRTA) quarterly Current Deferred Tax Assets came in at $174000.0 in Q3 2015, up 95.51% year-on-year from $89000.0 in Q3 2014, and up 5.45% quarter-over-quarter from $165000.0 in Q2 2015.

Prothena Corp Public (PRTA) Current Deferred Tax Assets (2012 - 2015) Analysis & Trends

Prothena Corp Public's Current Deferred Tax Assets history runs 4 years deep, the most recent figure standing at $174000.0 for Q3 2015.

  • On a quarterly basis, Current Deferred Tax Assets rose 95.51% year-over-year to $174000.0 in Q3 2015; TTM through Sep 2015 was $174000.0, a 95.51% increase from a year earlier, with the FY2014 full-year figure at $167000.0, up 106.17% from the prior year.
  • Current Deferred Tax Assets rose to $174000.0 in Q3 2015 per PRTA's latest filing, from $165000.0 in the prior quarter.
  • Across five years, Current Deferred Tax Assets topped out at $267000.0 in Q3 2013 and bottomed at $73000.0 in Q4 2012.
  • The 4-year median for Current Deferred Tax Assets is $85500.0 (2014), against an average of $123666.7.
  • Across the five-year window, Current Deferred Tax Assets slumped 66.67% in 2014 and surged 111.69% in 2015, its largest moves.
  • Year by year, Current Deferred Tax Assets stood at $73000.0 in 2012, then gained by 10.96% to $81000.0 in 2013, then surged by 106.17% to $167000.0 in 2014, then grew by 4.19% to $174000.0 in 2015.
  • Per Business Quant, the three latest PRTA Current Deferred Tax Assets figures stand at $174000.0 (Q3 2015), $165000.0 (Q2 2015), and $163000.0 (Q1 2015).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Prothena Corp Public 467.80 Mn 138.33 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2015 174,000.00
Sep 30, 2015 174,000.00
Jun 30, 2015 165,000.00
Jun 30, 2015 165,000.00
Mar 31, 2015 163,000.00
Mar 31, 2015 163,000.00
Dec 31, 2014 167,000.00
Dec 31, 2014 167,000.00
Sep 30, 2014 89,000.00
Sep 30, 2014 89,000.00
Jun 30, 2014 82,000.00
Jun 30, 2014 82,000.00
Mar 31, 2014 77,000.00
Mar 31, 2014 77,000.00
Dec 31, 2013 81,000.00
Dec 31, 2013 81,000.00
Sep 30, 2013 267,000.00
Sep 30, 2013 267,000.00
Jun 30, 2013 73,000.00
Jun 30, 2013 73,000.00